Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine | Scientific Reports
CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy - ScienceDirect
Frontiers | Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease
Frontiers | Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8+ T-Cells in Advanced Liver Disease
Frontiers | Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity
Frontiers | The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019
Hepatitis C virus - Wikipedia
Hepatitis C Virus (HCV) and the Role of Phytochemicals in the Anti-Viral Effects of Different Medicinal Plants Against Infection | SpringerLink
Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn? | Journal of Medicinal Chemistry
Hepatitis C virus - Wikipedia
Frontiers | Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment
PDF) HCV Core Protein–ISX Axis Promotes Chronic Liver Disease Progression via Metabolic Remodeling and Immune Suppression
Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment - eBioMedicine
Hepatitis C Virus (HCV) and the Role of Phytochemicals in the Anti-Viral Effects of Different Medicinal Plants Against Infection | SpringerLink
Molecules | Free Full-Text | Identification of Potential HCV Inhibitors Based on the Interaction of Epigallocatechin-3-Gallate with Viral Envelope Proteins
Frontiers | Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity
Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn? | Journal of Medicinal Chemistry
Apolipoprotein E and viral infection: Risks and Mechanisms: Molecular Therapy - Nucleic Acids
Virology and cell biology of the hepatitis C virus life cycle – An update - ScienceDirect
Suppression of Hepatitis C Virus Replication by Cyclosporin A Is Mediated by Blockade of Cyclophilins - ScienceDirect
Influence of HLA‐C environment on the spontaneous clearance of hepatitis C in European HIV–HCV co‐infected individuals - Legrand - 2021 - Clinical & Experimental Immunology - Wiley Online Library
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions - ScienceDirect
Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages | Digestive Diseases and Sciences
HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape - ScienceDirect
Hepatitis C virus - Wikipedia
Galactose Functionalized Mesoporous Silica Nanoparticles As Delivery Vehicle in the Treatment of Hepatitis C Infection | ACS Applied Bio Materials
HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape - ScienceDirect
